Affordable Inhalers and Nebulizers Act of 2025
See how your representatives voted on this bill.
DeepSyte matches this bill to the issues you care about and shows whether your reps' votes line up — not party, not press releases. Take the 2-minute values quiz to see your alignment.
Alignment with your views
Sign in and take the values quiz to see how this bill lines up with what you've said.
Summary
The Affordable Inhalers and Nebulizers Act of 2025 amends federal health insurance law to reduce patient cost-sharing for prescription inhalers and nebulizers used to treat asthma and chronic obstructive pulmonary disease. The bill caps cost-sharing at $15 per 30-day supply and eliminates deductibles for these medications in private insurance plans, Medicare Part B, and Medicare Part D, effective January 1, 2026. The bill also includes provisions for a payment program for uninsured individuals (text truncated before full details).
Values analysis
Sign in and take the values quiz to get a personalized read on how this bill lines up with your positions.
How your representatives voted
Sign in to see how your representatives voted on this bill.